Blood typing reagents

Active Awarded Last action

Contract number
36C25722A0018
Awardee
Awarding agency
Task orders
5 $82,572 obligated

Award facts

Opportunity
Combined order value
$82,572 Current and potential, with all options
Last date to order 91% complete
IDV ceiling 66% used
$125,000.00
Maximum order
$25,000.00
Award type
Single award
Who can order
Only the awarding agency
Contracting staff
Set-aside
Total Small Business
Competition
Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price

Award details come from SAM.gov/FPDS.

About this IDV

Alba Bioscience, Inc., a Chicago-based subsidiary of Quotient Biodiagnostics, Inc., was awarded a single-award Blanket Purchase Agreement valued at $125,000 by Veterans Integrated Service Network 17 (VISN 17) under the General Services Administration (GSA) Schedule 65-VII for In Vitro Diagnostics, Reagents, and Tests. The BPA, awarded April 1, 2022, with an ultimate completion date of March 31, 2027, supports the procurement of blood typing reagents and related immunohematology products essential for transfusion services and diagnostic testing across VA medical facilities. The award was designated as a Total Small Business set-aside, though Alba Bioscience typically competes competitively in the federal marketplace based on its specialized product offerings. The pre-solicitation opportunity was posted February 1, 2022, with a due date of February 8, 2022, indicating a streamlined acquisition process through the existing GSA Schedule contract vehicle.

The contract deliverables encompass a comprehensive portfolio of blood banking materials, including Alba Bioscience's proprietary ALBACLONE monoclonal antibodies targeting multiple blood group antigens, ALBACYTE antibody identification panels in various cell configurations, antibody screening products, ALBASURE quality control kits, and specialized additives such as ALBAHANCE bovine serum albumin and LISS solutions. Four documented task orders issued between April 2022 and April 2025, each valued at $16,514.42 with twelve-month performance periods, demonstrate consistent utilization of the BPA across VISN 17 locations in Pennsylvania, Texas, and Illinois. These recurring annual orders reflect the mission-critical nature of blood banking supplies to VA healthcare operations and Alba Bioscience's established position as a trusted supplier of specialized immunohematology reagents within the federal healthcare system, with task order activity extending through March 31, 2026.

Task orders

Transactions

Action Obligated Date
Exercise an Option P00004 · OPT MOD - STX quotient blood typing reagents - OY4 $0
Exercise an Option P00003 · Blood typing reagents - oyiii $0
Exercise an Option P00002 $0
Exercise an Option P00001 $0
Original award $0

Quick answers

Who was awarded contract 36C25722A0018?

36C25722A0018 was awarded to Alba Bioscience, Inc. by Veterans Integrated Service Network 17 (Veterans Health Administration) on April 1, 2022.

How much is contract 36C25722A0018 worth?

Orders under 36C25722A0018 have obligated $82,572. 36C25722A0018's own ceiling is $125,000. A single order can be worth up to $25,000.

How many orders have been placed under contract 36C25722A0018?

5 orders have been placed under 36C25722A0018, the latest on April 1, 2026.

Who can order from contract 36C25722A0018?

36C25722A0018 is a single award blanket purchase agreement. Only the awarding agency can place orders on it.

Is contract 36C25722A0018 under another contract?

Yes. 36C25722A0018 is a blanket purchase agreement under 36F79721D0259, a federal supply schedule, on Invitro Diagnostics, Reagents, Test (FSS-65-VII).

Was contract 36C25722A0018 competed?

The extent of competition for 36C25722A0018 was full and open competition. The government received 2 offers. It was set aside: Total Small Business.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV